Skip to main content
. 2014 Sep;58(9):5613–5616. doi: 10.1128/AAC.02973-14

TABLE 2.

In vitro antifungal susceptibility profile of H. capsulatum isolates reported globally

Location of isolation by continent Yr of isolation No. investigated (+ no. of reference strains investigated) (dimorphic form)a Method used (source) MIC/MIC range (μg/ml) forb:
Reference or source
AMB ITC VRC POS ISA FLU CAS/MFG/AFGc RAV
North America
    St. Louis, MO 1990 8 + 4 (Y) Broth microdilution using SDBd 0.30 to 1.04 2.95 to >1,000 12
    Indiana 1997 1 (Y) Broth macrodilution (NCCLS) 0.004 0.62 (parent), 1.25 (8th wk), 2.5 (12th wk), 20 (16th wk) 14
    Virginia 1998 5 (M) Broth microdilution (NCCLS) 0.25 to 0.5 0.06 0.06 15
    Virginia 1998 5 (M) Broth microdilution (NCCLS) 0.04 CAS, 1.3; AFG, 3.6 16
    Indiana 2000 20 (Y) Modified broth microdilution (NCCLS M-27A) 0.5 to 1 8 to 32 11
    Texas 2000 100 (M) Modified broth microdilution (NCCLS M-27A) <0.03 to 2 <0.03 to 0.5 <0.03 to 2 17
    Indiana 2001 65 (M) Modified broth microdilution (NCCLS M-27A) 0.019 to 0.077 0.31 to 10 8
    Virginia 2003 4–5 (M) Broth macrodilution (NCCLS M38-A) 0.06 to 0.5 <0.01 to 0.03 <0.03 to 0.06 1 to 16 CAS, 0.5 to 4; AFG, 2 to 4; MFG, >0.03 to 0.06 18
    Mexico 2005 28 (M) Broth macrodilution (NCCLS M38-A) 0.06 to 1 0.06 to 2 0.03 to 2 2 to 32 0.125 to 2 19
    Indiana 2006 17 (median MIC) (Y) Broth microdilution (NCCLS M-27A) 0.015 0.007 1 0.007 20
    Mexico 2009 28 (M) Broth macrodilution (CLSI M38-A) 0.06 to 0.25 0.25 to 2 0.06 to 2 0.03 to 2 0.125 to 2 4 to 32 9
South America
    Brazil 2012 68 (M) Modified broth microdilution (NCCLS M38-A) 0.007 to 0.5 0.001 to 0.031 0.0078 to 0.5 3.9 to 125 0.016 to 32 21
8 (Y) Modified broth microdilution (CLSI M27-A2) 0.06 to 0.5 0.0039 to 0.03 0.002 to 0.03 3.9 to 7.8 1 to 4
Asia
    Japan 2010 3 (M) Modified broth microdilution (CLSI M38-A) 0.013 to 0.05 <0.0004 0.006 to 0.025 0.003 to 0.006 0.55 to 1.2 22
    India 2014 21 + 2 (M) Modified broth microdilution (CLSI M38-A2) 0.03 to 0.25 <0.03 to 0.125 <0.03 to 0.25 0.015 to 0.125 0.015 to 0.25 2 to 32 0.015 to 0.5 Present study
21 + 2 (Y) Modified broth microdilution (CLSI M27-A3) 0.03 to 0.5 0.03 to 0.25 0.03 to 0.5 0.03 to 0.5 0.015 to 0.125 2 to 8 0.03 to 1
a

M, mycelial form; Y, yeast form.

b

AMB, amphotericin B; ITC, itraconazole; VRC, voriconazole; POS, posaconazole; ISA, isavuconazole; FLU, fluconazole; CAS, caspofungin; RAV, ravuconazole; MFG, micafungin; AFG, anidulafungin.

c

For caspofungin, MEC were defined for testing the mycelial form.

d

SDB, Sabouraud's dextrose broth.